Association of serum TNF-α, IL-8 and free light chain with HLA-DR B alleles expression in pulmonary and extra-pulmonary sarcoidosis

[1]  K. Mertz,et al.  Granulomas are a source of interleukin-33 expression in pulmonary and extrapulmonary sarcoidosis. , 2014, Human pathology.

[2]  M. Tomonaga,et al.  A Japanese patient with Löfgren's syndrome with an HLA-DR12 allele and review of literature on Japanese patients. , 2014, The Tohoku journal of experimental medicine.

[3]  E. Hachulla,et al.  Serum free light chains of immunoglobulins as biomarkers for systemic sclerosis characteristics, activity and severity. , 2014, Autoimmunity reviews.

[4]  M. Jolly,et al.  Serum free light chains, interferon-alpha, and interleukins in systemic lupus erythematosus , 2014, Lupus.

[5]  J. Garcia,et al.  Rituximab in the treatment of refractory pulmonary sarcoidosis , 2014, European Respiratory Journal.

[6]  I. Adcock,et al.  Immunopathology of sarcoidosis. , 2014, Iranian journal of allergy, asthma, and immunology.

[7]  V. Pascual,et al.  Transcriptional Blood Signatures Distinguish Pulmonary Tuberculosis, Pulmonary Sarcoidosis, Pneumonias and Lung Cancers , 2013, PloS one.

[8]  P. Thomas,et al.  Sarcoidosis: Immunopathogenesis and Immunological Markers , 2013, International journal of chronic diseases.

[9]  P. Ravaud,et al.  Serum Levels of Beta2-Microglobulin and Free Light Chains of Immunoglobulins Are Associated with Systemic Disease Activity in Primary Sjögren’s Syndrome. Data at Enrollment in the Prospective ASSESS Cohort , 2013, PloS one.

[10]  D. Radojković,et al.  Tumor necrosis factor alpha gene polymorphism in serbian patients with sarcoidosis. , 2013, Srpski arhiv za celokupno lekarstvo.

[11]  K. Maruyama,et al.  Simultaneous analysis of multiple cytokines in the vitreous of patients with sarcoid uveitis. , 2012, Investigative ophthalmology & visual science.

[12]  I. Adcock,et al.  Inflammasome signaling in pathogenesis of lung diseases. , 2012, Current pharmaceutical design.

[13]  S. M. Akula,et al.  Disturbed Homeostasis and Multiple Signaling Defects in the Peripheral Blood B-Cell Compartment of Patients with Severe Chronic Sarcoidosis , 2011, Clinical and Vaccine Immunology.

[14]  Michael C Iannuzzi,et al.  Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics. , 2011, JAMA.

[15]  P. Spagnolo,et al.  Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. , 2010, Human molecular genetics.

[16]  P. Tak,et al.  Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity , 2010, Annals of the rheumatic diseases.

[17]  D. Hommes,et al.  Ig-Free Light Chains Play a Crucial Role in Murine Mast Cell-Dependent Colitis and Are Associated with Human Inflammatory Bowel Diseases , 2010, The Journal of Immunology.

[18]  J. Garssen,et al.  Contribution of IgE and immunoglobulin free light chain in the allergic reaction to cow's milk proteins. , 2010, The Journal of allergy and clinical immunology.

[19]  D. Powe,et al.  Evidence for the involvement of free light chain immunoglobulins in allergic and nonallergic rhinitis. , 2010, The Journal of allergy and clinical immunology.

[20]  X. Mariette,et al.  Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort , 2009, Arthritis research & therapy.

[21]  G. Galluccio,et al.  Human neutrophil peptides stimulate tumor necrosis factor-alpha release by alveolar macrophages from patients with sarcoidosis. , 2009, Chest.

[22]  F. Redegeld,et al.  Atopic and non‐atopic allergic disorders: current insights into the possible involvement of free immunoglobulin light chains , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[23]  V. Žugić,et al.  Differences in symptom severity and health status impairment between patients with pulmonary and pulmonary plus extrapulmonary sarcoidosis. , 2008, Respiratory medicine.

[24]  G. Folkerts,et al.  Salmeterol with fluticasone enhances the suppression of IL-8 release and increases the translocation of glucocorticoid receptor by human neutrophils stimulated with cigarette smoke , 2008, Journal of Molecular Medicine.

[25]  S. Holgate,et al.  Dynamics of pro-inflammatory and anti-inflammatory cytokine release during zcute inflammation in chronic obstructive pulmonary disease: an ex vivo study , 2008, Respiratory research.

[26]  F. Redegeld,et al.  Free immunoglobulin light chains: a novel target in the therapy of inflammatory diseases. , 2008, Trends in pharmacological sciences.

[27]  J. Cayuela,et al.  Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjögren’s syndrome , 2006, Annals of the rheumatic diseases.

[28]  Gert Folkerts,et al.  Toll-like receptor-4 mediates cigarette smoke-induced cytokine production by human macrophages , 2006, Respiratory research.

[29]  A. Kraneveld,et al.  Free immunoglobulin light chains as target in the treatment of chronic inflammatory diseases. , 2006, European journal of pharmacology.

[30]  R. Wassmuth,et al.  SARCOIDOSIS AND AUTOIMMUNITY: EVIDENCE OF DIFFERENTIAL ASSOCIATIONS WITH HLA CLASS II MARKERS , 2006 .

[31]  D. Postma,et al.  Elicitation of allergic asthma by immunoglobulin free light chains. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[32]  F. Redegeld,et al.  Immunoglobulin free light chains and mast cells: pivotal role in T-cell-mediated immune reactions? , 2003, Trends in immunology.

[33]  R. Pandey,et al.  Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians. , 2003, American journal of respiratory cell and molecular biology.

[34]  G. Malerba,et al.  Complement receptor 1 gene polymorphisms in sarcoidosis. , 2002, American journal of respiratory cell and molecular biology.

[35]  M. Martinetti,et al.  HLA and sarcoidosis: new pathogenetic insights. , 2002, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

[36]  J. Pandey,et al.  TNF-alpha, IL1-beta, and immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis. , 2002, Human immunology.

[37]  J. Grunewald,et al.  Angiotensin‐converting enzyme gene polymorphism in relation to HLA‐DR in sarcoidosis , 2002, Journal of internal medicine.

[38]  G. McLennan,et al.  Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). , 2001, American journal of respiratory and critical care medicine.

[39]  G. McLennan,et al.  Clinical characteristics of patients in a case control study of sarcoidosis. , 2001, American journal of respiratory and critical care medicine.

[40]  M. Iannuzzi,et al.  Familial risk ratio of sarcoidosis in African-American sibs and parents. , 2001, American journal of epidemiology.

[41]  L. Casali,et al.  Genetic aspects in sarcoidosis. , 2000, The European respiratory journal.

[42]  R. Baughman.  Design of a case control etiologic study of sarcoidosis (ACCESS). ACCESS Research Group. , 1999, Journal of clinical epidemiology.

[43]  M. Iannuzzi,et al.  The influence of T cell receptor and cytokine genes on sarcoidosis susceptibility in African Americans. , 1999, Human immunology.

[44]  J. Gerdes,et al.  TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. , 1999, European cytokine network.

[45]  U. Costabel,et al.  Pentoxifylline Inhibits TNF- α Production from Human Alveolar Macrophages , 1999 .

[46]  U. Costabel,et al.  Pentoxifylline inhibits TNF-alpha production from human alveolar macrophages. , 1999, American journal of respiratory and critical care medicine.

[47]  Moller Dr.  Involvement of T cells and alterations in T cell receptors in sarcoidosis. , 1998 .

[48]  P. Zipfel,et al.  Increased expression of proinflammatory chemokines in bronchoalveolar lavage cells of patients with progressing idiopathic pulmonary fibrosis and sarcoidosis. , 1998, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[49]  A. Solomon,et al.  Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains. , 1998, Clinical and experimental immunology.

[50]  D. Moller.  Involvement of T cells and alterations in T cell receptors in sarcoidosis. , 1998, Seminars in respiratory infections.

[51]  J. Grunewald,et al.  HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. , 1997, American journal of respiratory and critical care medicine.

[52]  L. Newman,et al.  Medical progress : Sarcoidosis , 1997 .

[53]  S. Ohno,et al.  Analysis of HLA-DM polymorphisms in sarcoidosis. , 1996, Human immunology.

[54]  E. Arbustini,et al.  Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. , 1996, American journal of respiratory and critical care medicine.

[55]  M. Spiteri,et al.  Pulmonary sarcoidosis: patterns of cytokine release in vitro. , 1996, The European respiratory journal.

[56]  S. Kunkel,et al.  Cytokine function during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Local and regional participation of IFN-gamma, IL-10, and TNF. , 1995, Journal of immunology.

[57]  T. Suzuki,et al.  Serum levels of interleukin-8 as a marker of disease activity in patients with chronic sarcoidosis. , 1995, Journal of medicine.

[58]  F. Meloni,et al.  Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. , 1994, American journal of respiratory and critical care medicine.

[59]  A. Thomson.  The cytokine handbook , 1994 .

[60]  P. Mehta,et al.  Urinary free kappa light chain levels in chronic progressive multiple sclerosis. , 1994, Pathobiology : journal of immunopathology, molecular and cellular biology.

[61]  P. Mehta,et al.  Increased free light chains in the urine from patients with multiple sclerosis , 1991, Neurology.

[62]  R. Strieter,et al.  Cellular and molecular aspects of granulomatous inflammation. , 1989, American journal of respiratory cell and molecular biology.

[63]  Y. Kawakami,et al.  Role of HLA-DR antigens in Japanese patients with sarcoidosis. , 2015, The American review of respiratory disease.

[64]  K. Goebel,et al.  Genetic aspects of sarcoidosis. Class II histocompatibility antigens and a family study. , 1987, Archives of internal medicine.

[65]  A. Bártová,et al.  [Genetic aspects of sarcoidosis]. , 1986, Casopis lekaru ceskych.

[66]  R. Schubotz.  [Extrapulmonary manifestations of sarcoidosis]. , 1983, Praxis und Klinik der Pneumologie.

[67]  R. Crystal,et al.  Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. , 1983, The New England journal of medicine.

[68]  F. Rømer,et al.  Free light chains of immunoglobulins in serum from patients with rheumatoid arthritis, sarcoidosis, chronic infections and pulmonary cancer. , 2009, Acta medica Scandinavica.

[69]  R. Crystal,et al.  Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. , 1981, The New England journal of medicine.

[70]  Joseph Waksberg,et al.  Sampling Methods for Random Digit Dialing , 1978 .

[71]  D. James,et al.  Course and prognosis of sarcoidosis around the world. , 1974, The American journal of medicine.